Danish pharmaceutical company Novo Nordisk reported that its second-quarter profit beat forecasts and raised its annual outlook. This was reported by Qazaqyia.kz citing Reuters.
The company's operating profit in the second quarter was higher than analysts' expectations. As a result, Novo Nordisk improved its forecast for 2026.
These results may be attributed to increased demand for the company's key products, including anti-obesity drugs.